Stacy Ann Coen
CIK 1814150 · SVP & CHIEF BUSINESS OFFICER · last filed 2025-06-12
Stacy Ann Coen is a SVP & CHIEF BUSINESS OFFICER who has filed 20 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for FBLG, was dated Jun 12, 2025. Across all open-market trades the lifetime net is −$4.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
20
-$4.86M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FBLG | Director | — | $0.93 | — | $0 | 2 | 2025-06-12 |
| ImmunoGen, Inc. (IMGN) Delisted | SVP & CHIEF BUSINESS OFFICER | 0 | $31.23 | $0 | -$4.86M | 18 | 2024-02-12 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-12 | FBLG | Grant (A) | — | $0 | EDGAR |
| 2024-08-27 | FBLG | Grant (A) | — | $0 | EDGAR |
| 2024-02-12 | ImmunoGen, Inc. (IMGN) Delisted | Disp (D) | −73,274 | $0 | EDGAR |
| 2024-02-06 | ImmunoGen, Inc. (IMGN) Delisted | Mixed | +9,767 | -$134.3K | EDGAR |
| 2024-02-05 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | ImmunoGen, Inc. (IMGN) Delisted | Mixed | +30,367 | $165.5K | EDGAR |
| 2023-12-05 | ImmunoGen, Inc. (IMGN) Delisted | Sell (S) | −3,826 | -$111.7K | EDGAR |
| 2023-11-17 | ImmunoGen, Inc. (IMGN) Delisted | Mixed | — | -$979.8K | EDGAR |
| 2023-09-11 | ImmunoGen, Inc. (IMGN) Delisted | Exer (M) | +26,006 | $200.0K | EDGAR |
| 2023-08-11 | ImmunoGen, Inc. (IMGN) Delisted | Mixed | — | -$929.9K | EDGAR |